Experience in Spain with the first patients in home hemodialysis treated with low-flow dialysate monitors


Por: Slon Roblero MF, Bajo Rubio MA, González-Moya M, Calviño Varela J, Pérez Alba A, Villaro Gumpert J, Cigarrán S, Vidau P, García Marcos S, Abáigar Luquin P, Coll Piera E, Gascón Mariño A, Espigares MJ, Molina MD and Molina P

Publicada: 1 jul 2022 Ahead of Print: 1 jul 2022
Resumen:
Home hemodialysis (HHD) with low-flow dialysate devices has gained popularity in recent years due to its simple design, portability, and ability to provide greater freedom of move-ment for our patients. However, there are doubts about the adequacy that this technology offers, since it uses monitors with low-flow bath and lactate. The aim of this study was to demonstrate the clinical benefits of low-flow HHD with the NxStage System One (R) recently introduced in Spain. We present the results of an observational, retrospective cohort study that included the first patients who started short daily HHD with this device in 12 Spanish centers. We analyzed the evolution of 86 patients at 0, 6 and 12 months, including data related to prescription, and evolution of biochemical parameters related to dialysis dose, anemia, mineral-bone metabolism; evolution of residual renal function, medication usage, and causes of withdrawal during the followup. We were able to demonstrate that this NxS-tage System One (R) monitor, in patients with HHD, have provided an adequate dialysis dose, with optimal ultrafiltration rate, with improvement of main biochemical markers of dialy-sis adequacy. The usage of this technique was associated to a decrease of antihypertensive drugs, phosphate binders and erythropoietin agents, with very good results both patient and technique survival. The simplicity of the technique, together with its good clinical out-comes, should facilitate the growth and utilization of HHD, both in incident and prevalent patients. (c) 2021 Sociedad Espanola de Nefrologia. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).

Filiaciones:
Slon Roblero MF:
 Complejo Hospitalario Navarra, IdiSNA, Navarra, España

Bajo Rubio MA:
 Hospital Universitario La Paz, Madrid, IdiPAZ, Madrid, España

:
 Hospital Universitari Dr. Peset, FISABIO, Valencia, España

Calviño Varela J:
 Hospital Lucus Augusti, Lugo, España

:
 Hospital General de Castellón, Castellón, España

Villaro Gumpert J:
 Hospital General de Valencia, Valencia, España

Cigarrán S:
 Hospital da Costa, Burela, España

Vidau P:
 Hospital Universitario Central de Asturias, Oviedo, España

García Marcos S:
 Hospital de Poniente, Almería, España

Abáigar Luquin P:
 Hospital Universitario de Burgos, Burgos, España

Coll Piera E:
 Fundacio Puigvert, Barcelona, España

Gascón Mariño A:
 Hospital Obispo Polanco de Teruel, Teruel, España

Espigares MJ:
 Hospital Virgen de las Nieves, Granada, España

Molina MD:
 Departamento de Matemáticas, Universidad de Alicante, San Vicente del Raspeig, Alicante, España

:
 Hospital Universitari Dr Peset, FISABIO, Departamento de Medicina, Universitat de València, Valencia, España
ISSN: 02116995





NEFROLOGIA
Editorial
SOC ESPANOLA NEFROLOGIA DR RAFAEL MATESANZ, HOSPITAL RAMON Y CAJAL CTR DE COLMENAR, KM 9,100, 28034 MADRID, SPAIN, España
Tipo de documento: Article
Volumen: 42 Número: 4
Páginas: 460-470
WOS Id: 000829079600009
ID de PubMed: 34393002
imagen gold, Green Published

FULL TEXT

imagen Published Version CC BY-NC-ND

MÉTRICAS